ArticleiScience2026

Hepatotoxicity of new-generation ALK inhibitors versus crizotinib in patients with non-small cell lung cancer: A systematic review and meta-analysis.

Xingxian Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.